In contrast, O-glycan-modifying sialyltransferase ST6GalNAcs reduces the binding affinity of galectins (galectin-1 and galectin-3) to the tumor cell surface, thereby inhibiting intravascular aggregation of tumor cells and consequent metastasis (75, 76). The gene discussed is LGALS1; the disease is neoplasm.